XML 21 R11.htm IDEA: XBRL DOCUMENT v3.3.1.900
Web Based Technology
12 Months Ended
Dec. 31, 2015
Web Based Technology [Abstract]  
WEB-BASED TECHNOLOGY

NOTE 5 – WEB-BASED TECHNOLOGY

 

The Company has capitalized costs in developing its web-based technology, which consisted of the following as of December 31, 2015 and 2014:

 

  2015  2014 
OptimizeRx web-based technology $154,133  $154,133 
SampleMD web-based technology  602,517   602,517 
SampleMD 2.0 web-based technology  537,877   440,477 
Subtotal, web-based technology  1,294,527   1,197,127 
Accumulated amortization  (954,057)  (692,484)
Web-based technology, net $340,470  $504,643 

 

Amortization is recorded using the straight-line method over a period of up to five years. During 2014, the Company launched its SampleMD 2.0 web-based technology. All remaining carrying value at December 31, 2015 relates to the SampleMD 2.0 web-based technology. Amortization expense for the web-based technology costs was $261,572 and $192,760 for the years ended December 31, 2015 and 2014, respectively.